Kaya Holdings Inc KAYS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.03
- Day Range
- $0.03–0.03
- 52-Week Range
- $0.03–0.09
- Bid/Ask
- $0.03 / $0.04
- Market Cap
- $737,246.76
- Volume/Avg
- 534 / 4,468
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 36.86
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Kaya Holdings Inc is a holding company. It pursues medical and recreational licenses for the growing, processing, and sale of marijuana in jurisdictions through its subsidiaries. The company owns and operates brands that produce, distribute, and sell premium cannabis products including flowers, concentrates, and cannabis-infused baked goods and candies. It mainly operates a vertically integrated seed-to-sale legal marijuana enterprise and its operations include medical marijuana dispensaries, medical marijuana grow-operations, the manufacturing of proprietary cannabis products, and research and development of medical-grade cannabis strains and extracts for pain relief and treatment of serious illnesses. The company operates the Kaya Shack brand of medical marijuana dispensaries.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- 19
- Website
- https://www.kayaholdings.com
Valuation
|
Metric
|
KAYS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 36.86 |
Price/Cash Flow | — |
Price/Earnings
KAYS
Financial Strength
|
Metric
|
KAYS
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.01 |
Interest Coverage | 2.58 |
Quick Ratio
KAYS
Profitability
|
Metric
|
KAYS
|
|---|---|
Return on Assets (Normalized) | −529.57% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
KAYS
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Qtttdpqnqd | Pzrx | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Tkgbchynm | Llvgblv | $68.1 Bil | |
HLN
| Haleon PLC ADR | Flpkpsc | Gjy | $36.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Xwzftrw | Snmt | $14.3 Bil | |
VTRS
| Viatris Inc | Xyrmqswrh | Zvtvq | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Xywmvxd | Xtmqh | $12.0 Bil | |
CTLT
| Catalent Inc | Kyjbvlnc | Cnfjxy | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Csmjqkqgp | Hfls | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Tytrqkcp | Ndts | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Ppqhhkpns | Ypdsxx | $3.4 Bil |